The star CAC 40 index rose by 27.87 points to 6,477.25 points around 9:50 a.m. after two sessions in which it had fallen by around 2%.
The rebound is "technical" confirms John Plassard, investment specialist at Mirabaud.
The trend was initiated Monday on Wall Street where operators had hunted for bargains.
Investor sentiment remains weighed down by “concerns about a slowdown in the global economy due to rising Covid-19 infections in China,” according to CMC Markets analyst Michael Hewson.
In Beijing, the number of new cases is increasing and the authorities are organizing a massive screening of 22 million inhabitants in order to isolate infected people as quickly as possible.
Even if the authorities have not mentioned the possibility of confinement, many Beijingers are frightened by the example of Shanghai where 25 million inhabitants have been subjected to harsh confinement since the beginning of April.
“The prolonged shutdown of factories in China is a risk for all countries in the zone (Asia) while monetary tightening will be necessary in most countries in the zone due to the evolution of inflation. domestic and external pressures", analyzes Christian Parisot of Aurel BGC.
On the monetary level, investors digested for several days the comments of the director of the American central bank, the Fed, Jerome Powell, who plans to raise the institution's key rates by half a percentage point in May.
Corporate results could give the equity markets a little boost, as was the case on Wall Street on Monday, where the indices opened lower before rebounding, driven by the Nasdaq which rose 1.29%.
The digital giants Alphabet and Microsoft will publish their quarterly results on Tuesday evening.
Orange stable, like its sales
The French telecoms giant Orange (-0.27% to 11.11 euros) recorded a turnover up 0.7% over one year, in the first quarter of 2022, to 10.58 billion euros.
Valneva positive
The Franco-Austrian laboratory Valneva (+ 7.18% to 13.88 euros) and Pfizer reported positive results on children aged 5 to 17 from their vaccine candidate against Lyme disease, as part of their trial of Phase 2.
Orpea reports its results
The manager of private nursing homes Orpea announced on Tuesday that it would postpone the publication of its annual accounts until May 13, citing the "exceptional circumstances currently being experienced by the company".
In turmoil since the publication of the book "Les Fossoyeurs" and accused of serious malfunctions, Orpea lost 2.47% to 33.60 euros on Tuesday morning.
© 2022 AFP